Imvax Company
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Technology:
Whole-Cell Antigens
Industry:
Whole-Cell Antigens
Headquarters:
Philadelphia, Pennsylvania, United States
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
6
Total Funding:
166700000
Estimated Revenue:
Less than $1M
Last Funding Date:
2020-07-16
Last Funding Type:
Series C
Register and Claim Ownership